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ABSTRACT 
Congenital erythroderma is a rare and often life-threatening condition, which has been shown to 
result from mutations in several genes encoding important components of the epidermal 
differentiation program. Using whole exome sequencing, we identified in a child with congenital 
exfoliative erythroderma, hypotrichosis, severe nail dystrophy and failure to thrive, two 
heterozygous mutations in ABCA12 (c.2956C>T, p.R986W; c.5778+2T>C, p. G1900Mfs*16), a 
gene known to be associated with 2 forms of ichthyosis, autosomal recessive congenital 
ichthyosis and harlequin ichthyosis. Because the patient displayed an atypical phenotype, 
including severe hair and nail manifestations, we scrutinized the exome sequencing data for 
additional potentially deleterious genetic variations in genes of relevance to the cornification 
process. Two mutations were identified in CAPN12, encoding a member of the calpain proteases: 
a paternal missense mutation (c.1511C>A; p.P504Q) and a maternal deletion due to activation of 
a cryptic splice site in exon 9 of the gene (c.1090_1129del ; p.Val364Lysfs*11). The calpain 12 
protein was found to be expressed in both the epidermis and hair follicle of normal skin but its 
expression was dramatically reduced in the patient’s skin. Down-regulation of capn12 expression 
in zebrafish was associated with abnormal epidermal morphogenesis. siRNA knockdown of 
CAPN12 in three-dimensional human skin models was associated with acanthosis, disorganized 
epidermal architecture and down-regulation of several differentiation markers, including 
filaggrin. Accordingly, filaggrin expression was almost absent in the patient skin. Using ex vivo 
live imaging, siRNA knockdown of calpain 12 in skin from K14-H2B GFP mice led to 
significant hair follicle catagen transformation compared to controls. In summary, our results 
indicate that calpain 12 plays an essential role during epidermal ontogenesis and normal hair 
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follicle cycling and that its absence may aggravate the clinical manifestations of ABCA12 
mutations. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
5 
 
INTRODUCTION 
Congenital erythroderma refers to a genetically and phenotypically heterogeneous group of 
disorders of cornification featuring generalized redness and scaling present at birth (Pruszkowski 
et al., 2000). Although congenital erythroderma has been associated with a number of acquired 
and hereditary disorders, the vast majority of cases are due to inherited mutations in genes 
encoding important components of the epidermal differentiation program.  Among the various 
etiologies associated with congenital erythroderma, autosomal recessive congenital ichthyoses 
(ARCIs) rank first (Pruszkowski et al., 2000). ARCIs are caused by mutations in genes encoding 
proteins involved in the formation of the epidermal barrier, such as ABCA12, encoding a 
transporter involved in lipid loading within epidermal lamellar granules (Oji et al., 2010).  
Congenital erythroderma is not only characterized by extensive genetic heterogeneity, it is also 
characterized by striking clinical variability, which has suggested the existence of modifying 
genetic variants responsible for aggravating or attenuating disease phenotypes (Cooper et al., 
2013).  The identification of modifier variants can sometimes reveal important biological 
functions. In the present study, the delineation of the molecular basis of an atypical case of 
congenital erythroderma revealed a hitherto unknown role for calpain 12 (CAPN12) during 
epidermal differentiation and hair follicle cycling.  
 
RESULTS 
 
Phenotype delineation 
A 6-week old boy was referred for investigation because of congenital erythroderma and failure 
to thrive. The patient was the second child of healthy unrelated parents of Palestinian Armenian 
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and Palestinian Catholic origin. He had a healthy brother and there was no family history of skin 
or hereditary diseases. The patient was born after 34 weeks of gestation. At birth, his skin was 
reddish and partly covered with thick grayish secretions, but his hair was normal. He was 
hospitalized in the pediatric intensive care unit, where he was treated with intravenous antibiotics 
during three episodes of sepsis associated with hypoglycemia and hypocalcemia. Over the first 
two weeks of life, the skin became red and scaly (Fig. 1a), and he progressively lost most of his 
hair. General and neurological examinations were normal. Apart from ectropion, 
ophthalmological examination was normal. Complete blood count, blood chemistry and IgE 
levels were normal. Blood smear was normal with no evidence of Jordan’s anomaly. Ultrasound 
examination of the abdomen and pelvis was unrevealing. Repeated echocardiograms and BERA 
hearing test were normal.  
Over the first two years of life, the patient failed to grow (currently below the 3rd percentile) but 
did not experience any additional infectious complications. Although his skin condition remained 
stable and some hair growth was noticed (Fig. 1b), massive overgrowth of his nail plates (Fig. 
1c) became evident at the age of one year, markedly interfering with daily function.  
A skin biopsy revealed a perivascular, psoriasiform dermatitis with parakeratosis and a relatively 
thin stratum corneum showing intracorneal splitting (Fig. 1d). Hair microscopy was 
unremarkable (not shown).  
 
Mutation analysis 
Because the patient’s clinical features (congenital erythroderma, skin peeling, hypotrichosis) 
were reminiscent of Netherton syndrome or related syndromes (Samuelov and Sprecher, 2014), 
we initially excluded mutations in SPINK5, CDSN and DSG1 by direct sequencing (not shown). 
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A DNA sample from the patient was then subjected to whole exome sequencing and data were 
initially scrutinized for mutations in genes known to be associated with disorders of cornification 
(Oji et al., 2010), leading to the identification of two heterozygous mutations in ABCA12 (Fig. 
2a): c.2956C>T, predicted to result in p.R986W substitution, and  c.5778+2T>C,  predicted to 
abolish a conserved donor splice site located in intron 38 and to result in p. G1900Mfs*16. 
Despite the fact that only one of the two mutations (p.R986W) has been published previously 
(Fukuda et al, 2012), a number of facts support the possibility that they are pathogenic. Both 
mutations were found to co-segregate with the disease phenotype (Fig. 2b). Mutation c.2956C>T 
was found in three out of 134,322 alleles deposited in public databases including NCBI, HGMD, 
UCSC, ENSEMBL, 1000 Genomes Project, ExAc and the NHLBI Grand Opportunity Exome 
Sequencing Project, while mutation c.5778+2T>C was not found in any of the public databases 
mentioned above.  Both mutations were excluded using PCR-RFLP assays from a cohort of 274 
and 207 population-matched non-affected individuals, respectively. Mutation p.R986W affects a 
highly conserved residue (Conseq = 9, range 1-9; http://conseq.tau.ac.il/) and is predicted to be 
damaging by Polyphen-2 (score = 1; http://genetics.bwh.harvard.edu/pph2/) and SIFT (Score = 
0; http://sift.jcvi.org/) software. To assess the consequences of mutation c.5778+2T>C, we 
sequenced cDNA derived from a patient skin biopsy with a primer pair encompassing exons 37-
39. As shown in Fig.2c, the mutation was found to result in an 88-bp deletion, due to exon 38 
skipping, which in turn, is likely to result in mRNA decay as demonstrated in Fig. 2c.  
As mentioned above, ABCA12 mutations have been shown to cause both ARCI and harlequin 
ichthyosis. Our patient clearly did not display a phenotype resembling harlequin ichthyosis, and 
hypotrichosis with exuberant nail growth is not typical of ARCI.  
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We therefore re-ascertained the whole exome sequencing data for additional deleterious 
sequence alterations of potential relevance to the skin phenotype displayed by the patient. We 
looked for rare and functionally relevant changes and therefore applied the following filtration 
criteria (Isakov et al., 2013a; Isakov et al., 2013b): MAF <0.01 (and no more than 25 carriers 
reported); high conservation as predicted by four bioinformatics software:  Conseq (Berezin et 
al., 2004) > 8, Phylop (Siepel et al., 2006) > 0.85, GERP (Pollard et al., 2010) > 1.5 and phast-
Cons-Elements-46way (Siepel et al., 2005); and deleterious effects on protein function as 
predicted by PolyPhen2 (Adzhubei et al., 2010) > 0.95 and SIFT (Kumar et al., 2009) < 0.05. 
Only one heterozygous transversion, c.1511C>A in CAPN12, passed all functional filters and is , 
predicted to result in p.P504Q substitution.  
CAPN12 encodes calpain 12, a calcium-activated cysteine protease, which belongs to a group of 
proteins which have been shown to play an important role in epidermal differentiation (Campbell 
and Davies, 2012; Ono and Sorimachi, 2012) and have recently been implicated in the 
pathogenesis of a human skin disease (Lin et al., 2015). Capn12 was shown in mice to be 
exclusively expressed in the skin (Dear et al., 2000). Accordingly, we found out that it is mainly 
expressed in human skin with weaker to almost absent expression in other tissues (Fig. S1). 
The mutation was identified by direct sequencing (Fig. 2d) and a PCR-RFLP assay (Fig. 2e) in 
the patient, his father and his brother, but not in the patient’s mother. The mutation was found in 
two out of 25,126 alleles deposited in public databases including NCBI, HGMD, UCSC, 
ENSEMBL, 1000 Genomes Project, ExAc and the NHLBI Grand Opportunity Exome 
Sequencing Project. Using the PCR-RFLP assay described above, we excluded the mutation 
from a panel of 176 population-matched healthy controls. The mutation affects a highly 
conserved amino acid residue (Conseq = 9, range 1-9) and is likely to be damaging to the protein 
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function (SIFT score = 0, Polyphen-2 score = 0.997). The sequence of CAPN12 (NP_653292.2) 
was submitted to the Phyre2 Protein Fold recognition server 
(http://www.sbg.bio.ic.ac.uk/phyre2/html /page.cgi?id=index) to obtain a molecular model. A 
large number of Calpain and Calpain-like structures have been experimentally determined and 
deposited in the Protein Data Bank (http://www.rcsb.org/pdb/home/home.do). CAPN12 was 
modeled according to the human m-calpain large subunit structure (PDB code 1KFX:L) with a 
statistical confidence of 100% (residues 1-719). The site of the mutation P504 is located within 
the central domain of the protein, which includes a large β-sandwich motif (Fig. S2). This 
domain is surrounded by the N-terminal and C-terminal domains and likely stabilizes the entire 
protein fold. The proline pyrrolidine side chain faces into the sandwich interface directly facing 
and participating in a highly hydrophobic core that includes W363, F359 and F385. Mutation of 
the polar and bulky glutamine residue is predicted to have a disrupting effect on this hydrophobic 
core, destabilizing the sandwich interactions. 
Full sequencing of the entire coding and non-coding (including the promoter region) sequence of 
CAPN12 in the proband and his mother failed to reveal a second pathogenic sequence alteration. 
However, direct sequencing of a cDNA sample derived from a skin biopsy obtained from the 
patient revealed a 40 bp deletion, presumably due to activation of a cryptic splice site within 
exon 9 of the gene (Fig. 2f). The heterozygous mutation c.1090_1129del is predicted to result in 
frameshift, premature protein termination (p.Val364Lysfs*11) and most likely, nonsense-
mediated mRNA decay. To confirm segregation of the mutation with the disease phenotype, we 
obtained skin biopsies from the patient’s parents. Using direct sequencing of biopsy-derived 
cDNA, we demonstrated the presence of the c.1090_1129del mutation in the cDNA generated 
from the patient’s mother, but not in the cDNA generated from the patient’s father (not shown). 
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Because we failed to identify any DNA or RNA sequence alteration which could have caused 
activation of the cryptic splice site in exon 9 of the CAPN12 gene, we hypothesized that 
epigenetic changes may possibly underlie this phenomenon. Indeed, a steadily growing body of 
evidence suggests that exonic DNA methylation is associated with increased alternative splicing 
(Lev Maor et al., 2015; Malousi and Kouidou, 2012; Maunakea et al., 2013). We therefore 
compared DNA methylation pattern in the patient, his parents and control individuals. Both the 
patient and his mother demonstrated significantly increased DNA methylation in exon 9 (Fig. 
2g), as compared with all other DNA samples. Of interest, these differences in methylation status 
were noticed in keratinocytes but not in peripheral blood lymphocytes (not shown), suggesting 
that hypermethylation-associated alternative splicing within CAPN12 may be tissue-specific, as 
previously shown for other genes (Gutierrez-Arcelus et al., 2015).  To assess the functional 
consequences of the presence of the two deleterious CAPN12 mutations that were identified in 
the patient, we compared the pattern of expression of calpain 12 in the skin of the patient and in 
normal skin. As shown in Fig. 3a, calpain 12 is strongly expressed in normal epidermis, as 
previously shown in murine skin, but was absent in the patient skin. Using qRT-PCR, we found 
out that CAPN12 RNA levels were 8-fold lower in the patient skin as compared with normal skin 
(Fig. 3b). 
 
Delineation of CAPN12 function in the epidermis 
Little is currently known about the function of calpain 12 in the epidermis (Dear et al., 2000). 
Over the past few years, the zebrafish has become recognized as a useful model to ascertain the 
importance of mediators of human epidermal development (Li and Uitto, 2013). We therefore 
down-regulated the expression of capn12 in zebrafish using a gene-specific morpholino (Fig. 
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S3). Scanning electron microscopy of morphant larvae at 3 dpf revealed abnormally large KCs 
with aberrant microridge formation as compared with normal keratinocytes in control larvae 
(Fig. 4 a-b).  In addition, transmission electron microscopy analysis demonstrated almost 
complete absence of microridges in the morphant larvae (Fig. 4 c-d) which also developed 
pericardial edema and curled tail phenotype (Fig.4 e-f), associated with death at 6-8 dpf.  
We then used two in vitro models to determine whether calpain 12 is involved in epidermal 
differentiation and hair cycling. First, using siRNA, we down-regulated CAPN12 expression in 
primary keratinocytes and used these keratinocytes to generate three-dimensional skin 
equivalents (Fig. S4). As shown in Fig. 5a and Fig. S5, CAPN12 down-regulation resulted in a 
disorganized epidermal architecture associated with mild acanthosis, suggesting abnormal 
differentiation. Keratin gene expression was also consistent with abnormal epidermal 
differentiation (Fig. 6S).  We therefore analyzed the pattern of expression of filaggrin, which has 
been shown to be a substrate of calpains38 and is a marker of terminal differentiation in the 
epidermis. Filaggrin was almost absent and mislocalized in organotypic skin equivalents down-
regulated for CAPN12, as well as in the skin of the patient (Fig. 5 b-c). Of note, ABCA12 gene 
expression, as assessed by qRT-PCR, was elevated in organotypic skin equivalents down-
regulated for CAPN12 while protein expression was not significantly different (not shown).  
We considered the possibility that filaggrin deficiency in the patient skin may have been the 
result of bi-allelic mutations in the FLG gene. To rule out this possibility, the FLG gene was 
fully sequenced, which revealed no loss-of-function mutations (not shown).  We also assessed 
the possibility that filaggrin deficiency may be related to ABCA12 dysfunction. However, as 
previously shown (Akiyama et al., 1996), we found normal to increased filaggrin expression in 
the skin of patients carrying bi-allelic null mutations in the ABCA12 gene (Fig. 5d). We also 
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attempted to generate skin equivalents deficient for both calpain 12 and ABCA12, but were 
unable to obtain epidermal differentiation in these double knock down skin models (not shown).  
Second, we used K14 H2B-GFP mice to assess by ex vivo live imaging the effect of Capn12 
down-regulation on hair cycling (Fig. S7, Supplementary movies 1-3). As shown in Fig. S8, we 
achieved efficient down regulation of calpain 12 expression in skin strips derived from those 
mice. Live imaging revealed that calpain 12 down-regulation induced catagen-like 
transformation in hair follicles (Fig. 6). Many hair follicles treated with Capn12 siRNA showed 
evidence of increased apoptotic activity (Fig. S9), suggesting that calpain 12 expression is 
essential for normal hair follicle cycling. 
 
DISCUSSION 
Disorders of cornification, and ARCI more specially, are known to be characterized by clinical 
heterogeneity (Oji et al., 2010), which in turn very much complicates both the diagnosis and the 
genetic counseling of families at risk for these disorders. Apart from the effect of filaggrin 
deficiency on the clinical manifestations of X-linked recessive ichthyosis (Liao et al., 2007) and 
pachyonychia congenital (Gruber et al., 2009), very little is currently known about genetic 
modifiers of clinical phenotypes in disorders of cornification. Here, we identified bi-allelic 
deleterious mutations in CAPN12 in a child with exfoliative erythroderma carrying 2 mutations 
in ABCA12. Although congenital erythroderma can be a consequence of mutations in ABCA12, 
several clinical (severe hypotrichosis and exuberant nail plate growth) and pathological (loss of 
epidermal architecture and lack of hyperkeratosis) features were deemed atypical of ARCI. 
Severe alopecia has been reported in the context of harlequin ichthyosis but ARCI is usually 
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associated with no or a mild hair phenotype as previously shown in a patient carrying p.R986W 
and a splice sire mutation (Fukuda et al., 2012).  
Calpains form a large family of 14 distinct calcium-dependent cysteine proteinases which share a 
similar protease domain (Goll et al., 2003). They have been shown to regulate major cellular 
functions including apoptosis and cell motility and have been implicated in the pathogenesis of 
human diseases including cancer, cardiovascular and neurodegenerative disorders (Miyazaki et 
al., 2013; Momeni, 2011; Ono and Sorimachi, 2012; Sorimachi et al., 2012; Storr et al., 2011; 
Vosler et al., 2008). Several lines of evidence suggest that calpains may play an important role in 
cutaneous biology. Calpain inhibition was found to be associated with abnormal cornification 
(Kim and Bae, 1998) and delayed wound healing (Nassar et al., 2012) while calpain activity was 
also found to be necessary for staphylococci to break through the epidermal barrier (Soong et al., 
2012). More recently, calpastin, a calpain inhibitor, was found to be absent in the skin of patients 
with PLACK syndrome (MIM 616295), which is characterized by peeling skin, leukonychia, 
acral keratosis, cheilitis, and keratoderma as well as by loss of epidermal cell-cell adhesion (Lin 
et al., 2015). Although most calpains are distributed ubiquitously, a minority of these proteinases 
are expressed in a tissue-specific fashion, including calpain 12 which is predominantly expressed 
in the skin (this study and (Dear et al., 2000)).  
Here we show that calpain 12 plays a pivotal role in epidermal differentiation and hair follicle 
cycling. In agreement with our data, a recent paper identified capn12 as essential for skin 
integrity in zebrafish (Westcot et al., 2015). Although the exact mechanism underlying calpain 
12 mode of action during epidermal differentiation remains to be determined, the 
histopathological findings secondary to CAPN12 down-regulation in three-dimensional models 
suggest that calpain 12 deficiency may interfere with the normal processing and/or activation of 
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critical components of the cornified cell envelope. This hypothesis is in line with earlier studies 
which suggested that calpains contribute to epidermal maturation by activating transglutaminase 
1 and promoting the processing of filaggrin (Kim and Bae, 1998; Resing et al., 1993; Yamazaki 
et al., 1997). In fact, filaggrin expression was markedly reduced and mislocalized in the skin of 
the patient. The fact that down-regulation of CAPN12 in three-dimensional skin equivalents was 
also associated with filaggrin deficiency argues for a direct role of calpain 12 in the regulation of 
filaggrin expression in the differentiating epidermis. Filaggrin deficiency could in part underlie 
the unusual severity of this patient’s condition as FLG mutations have been associated with both 
epidermal and follicular phenotypes (Meng et al., 2014), although it is possible that other 
abnormalities (e.g. abnormal expression of adhesion molecules, which are known to play an 
important role in the regulation of cornification(Harmon et al., 2013)) are also responsible for the 
overall severe phenotype displayed by the patient. 
Recently, another atypical case of ARCI caused by mutations in NIPAL4 was also shown to be 
associated with modifying genetic variations in genes modulating epidermal differentiation 
(Kiritsi et al., 2015), substantiating the notion that the phenotypic variability typical of ARCI 
could often be attributable to minor genetic variants in genes encoding elements of the epidermal 
differentiation program.  
In summary, we have shown that calpain 12 plays a crucial role in interfollicular and follicular 
epidermal differentiation. In addition, calpain 12 deficiency may modify the clinical 
consequences of ABCA12 mutations, although its role as a genetic modifier remains to be 
confirmed in additional cases. Given initial studies showing involvement of calpains in the 
pathogenesis of both inherited (Lin et al., 2015) and acquired (Gutowska-Owsiak et al., 2012; 
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Meephansan et al., 2012) cutaneous disorders, the present observations warrant investigating 
calpain 12 as a potential therapeutic target for some of these conditions.   
 
MATERIALS AND METHODS 
 
Patients  
All affected and healthy family members or their legal guardian provided written and informed 
consent according to a protocol approved by our institutional review board and by the Israel 
National Committee for Human Genetic Studies in adherence with the Helsinki principles.  
 
Exome sequencing  
Details regarding exome sequencing can be found in Supplementary materials and methods.  
 
Mutation analysis  
Technical details regarding mutation analysis and direct sequencing can be found in 
Supplementary materials and methods.  
 
PCR-restriction fragment length polymorphism (RFLP) 
Technical details regarding the design and execution of these assays can be found in 
Supplementary materials and methods.  
 
Bisulfite sequencing 
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Technical details regarding the design and execution of bisulfite sequencing can be found in 
Supplementary materials and methods.  
 
 
Quantitative RT-PCR 
Technical details regarding quantitative RT-PCR can be found in Supplementary materials and 
methods.  
 
Cell cultures and reagents 
Primary KCs and fibroblasts were isolated from adult skin obtained from plastic surgery 
specimens after having received written informed consent from the donors according to a 
protocol reviewed and approved by our institutional review board as previously described 
(Samuelov et al., 2013). Primary KCs were maintained in Keratinocytes Growth Medium 
(KGM) (Lonza, Walkersville, MD). Fibroblasts were cultured in Dulbecco’s Modified Essential 
Medium (DMEM) supplemented with 20% fetal calf serum (FCS) (Biological Industries). 
 
siRNA transfection  
Primary KCs and fibroblasts were cultured in 100-mm culture plates at 37°C in 5% CO2 in a 
humidified incubator and were harvested at 60% confluence. To down regulate CAPN12 
expression, we used human CAPN12 small interference RNAs (siRNA) (Santa Cruz; sc-62060) 
(5`-GAACAGCGGAAUGAGUUCUtt-3`, 5`-CAAUCCUCAGUUCCGUUUAtt-3` and 5`-
CGUACUCCUCACUCAGAAAtt-3`). As control siRNA, we used Stealth™ RNAi Negative 
Control Duplex (Invitrogen, Carlsbad, CA). One hundred eighty pmol of siRNAs were 
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transfected into primary KCs and fibroblasts using Lipofectamine RNAiMax (Invitrogen, 
Carlsbad, CA).The transfection medium was replaced after 6 hours with KGM (for KCs) or 
DMEM (for fibroblasts). Seventy two hours following transfection, the transfected cells were 
trypsinized and used for organotypic cell cultures as described below.  
 
Preparation of organotypic cell cultures 
Experimental details regarding the generation of organotypic cell cultures can be found in 
Supplementary materials and methods.  
 
Immunostaining 
Details regarding immunostaining techniques can be found in Supplementary materials and 
methods.  
 
Capn12 knock down in zebrafish and morphant analysis 
Details of the generation of capn12-deficient zebrafish embryos can be found in Supplementary 
materials and methods.  
 
Ex vivo hair follicle live imaging 
Details regarding the generation and use of K14 H2B-GFP+/+ mice to ascertain the effect of 
Capn12 deficiency on hair follicle can be found in Supplementary materials and methods.  
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Legends to figures 
 
Figure 1 
Clinical and pathological features 
The proband demonstrates (a) exfoliative erythroderma, (b) hypotrichosis and thick yellowish 
scales over the scalp and (c) hypertrophic nails. (e) On histology, parakeratosis, acanthosis and 
mild perivascular dermatitis are seen (hematoxylin and eosin; scale bar = 100µm).  
 
Figure 2 
Mutations` analysis 
(a) Direct sequencing of ABCA12 revealed two heterozygous mutations: a C>T transition at 
position c.2956 of the DNA sequence (upper left panel) and a T>C transition at position 
c.5778+2 (upper right panel). The wild type (WT) sequences are given for comparison (lower 
panels); (b) A PCR-RFLP assay was used to assess co-segregation of the two ABCA12 mutations 
with the disease phenotype. The c.2956C>T and c.5778+2T>C mutations are associated with the 
presence of  594-bp and 186-bp fragments, respectively; (c) cDNA was reverse transcribed from 
RNA extracted from the skin of the patient and of a healthy individual (WT). cDNA was PCR-
amplified using primers spanning ABCA12 exons 37-39 (left panel). Direct sequencing of the 
resulting amplicons revealed a wild type mRNA sequence in both the patient and the healthy 
individual (upper right panel) as well as a shorter isoform due to exon 38 skipping, in the patient 
only (lower right panel); (d) Direct sequencing of CAPN12 revealed a heterozygous C>A 
transversion at position c.1511 of the cDNA sequence (upper panel). The wild-type (WT) 
sequence is given for comparison; (e) A PCR-RFLP assay was used to assess co-segregation of 
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the c.1511C>A mutation in CAPN12 with the disease phenotype. The mutation is associated with 
the presence of a 195-bp fragment; (f) cDNA was reverse transcribed from RNA extracted from 
the skin of the patient and PCR-amplified using primers spanning CAPN12 exon 8-10. Direct 
sequencing of the resulting amplicons revealed wild type mRNA sequence (upper panel) as well 
as a shorter sequence lacking the last 40 bp of exon 9 (lower panel); (g) DNA methylation 
analysis of CAPN12 exon 9 was performed using DNA extracted from keratinocytes derived 
from skin biopsies of the patient, his mother and father as well as two unrelated control 
individuals. For details see supplementary materials and methods. Results represent the mean 
results derived from the analysis of 10-15 clones per sample + SE (** p<0.05; *** p<0.01, two 
sided t-test).    
 
Figure 3 
CAPN12 expression in the skin.  
(a) A skin biopsy obtained from a healthy individual demonstrates by immunostaining 
cytoplasmic expression of calpain 12 in the epidermis (more pronounced in the lower epidermal 
layers) (left panel). In contrast, calpain 12 expression is markedly reduced in the skin of the 
patient (right panel) (dermo-epidermal junction is marked with a dotted line; scale bars = 100 
µm); (b) Quantitative RT-PCR analysis was used to assess CAPN12 RNA expression in cDNA 
samples derived from healthy individual skin and patient skin. Results represent the mean of 
three replicates and are provided as percentage of expression relative to gene expression in 4 
controls + SE normalized to ACTB mRNA levels. 
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Figure 4 
Capn12 knockdown in a zebrafish model.  
Zebrafish embryos were injected with a global standard control morpholino (scMO) (a,c,e) or 
with a Capn12-specific morpholino (b,d,f). Scanning electron microscopy analysis of the skin of 
the tail of a control larvae injected with scMO shows the presence of keratinocytes with well-
demarcated cell-cell borders containing well-defined microridges (a), while the morphant larvae 
injected with a splice site morpholino for Capn12 demonstrates perturbed microridge formation 
in the center of the keratinocytes with cracks and sloughing (b) (scale bar = 30 µm); 
Transmission electron microscopy analysis demonstrates normal microridge formation (arrows) 
in the control larva (c), while the formation of microridges in the morphant fish (d) is markedly 
perturbed (arrows). Asterisks mark the basement membrane. e, epidermis; d, dermis. Scale bar = 
500 nm; In contrast with the normal morphology of the control fish (e), the morphant fish 
developed pericardial edema and a curled tail phenotype associated with death at around 6-8 
days post-fertilization (f).  
 
 
 
 
 
 
 
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
27 
 
Figure 5 
CAPN12 knockdown in organotypic cell cultures  
(a-b) Human primary KCs transfected with CAPN12 siRNA (siCAPN12) or control siRNA 
(siControl) were used to generate skin equivalents. Punch biopsies were obtained from skin 
equivalents at day10 and stained for (a) hematoxylin and eosin or (b) filaggrin (bar = 100 µm); 
(c) Punch biopsies were obtained from control skin and from the patient (III-1) skin and stained 
for filaggrin (bar = 100µm). (d) Punch biopsies were obtained from control skin and from the 
skin of a patient with harlequin ichthyosis and biallelic null mutations in ABCA12 gene and 
stained for filaggrin (bar = 100µm). 
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Figure 6 
Effect of Capn12 down-regulation on hair follicle cycle 
(a-f) Z stacks optical sections of K14-H2B-GFP mouse anagen (a-c) and catagen (d-f) hair 
follicles treated with control siRNA and Capn12 siRNA, respectively. The anagen hair follicles 
show stationary location of epithelial nuclei (see supplementary movie 1) while the catagen hair 
follicles demonstrate upward movement of the epithelial nuclei (see supplementary movie 3) 
during 9:20 hours of imaging. Epithelial nuclei are marked with K14-H2BGFP. Three nuclei in 
anagen (a-c) and four nuclei in catagen (d-f) hair follicles are circled in colors. Scale bar = 100 
µm; (g) Anagen and catagen were ascertained as previously described (Foitzik et al., 2005; 
Samuelov et al., 2012). In brief, hair follicles were categorized as “alive” or “dead” based upon 
the presence of any movement of cells in the follicle. “Alive” hair follicles were further 
categorized as anagen or catagen hair follicles based upon the following defining parameters for 
catagen transformation: 1) hair bulb shrinkage and upward displacement of the bulb region; 2) 
upward displacement of epithelial nuclei in the bulb region; 3) apoptosis of epithelial cells with 
evidence of nuclear fragmentation. Three independent experiments were done with 3 different 
mice. In each mouse, 3 skin samples from each of the two treatment groups (Capn12-siRNA vs. 
control-siRNA) were used for ex vivo live imaging and in each sample the mean hair cycle score 
(HCS) was calculated as previously described (Foitzik et al., 2005; Samuelov et al., 2012). 
Results were pooled and are expressed as the mean HCS of all hair follicles per treatment group 
(*** p<0.001, t-test). 
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